The Global In Vitro Diagnostics (IVD) Quality Control Market size was valued at USD 92.08 billion in 2021. The market is projected to grow from USD 71.43 Billion in 2022 to USD 107.42 Billion by 2030, exhibiting a CAGR of 6.0% during the forecast.

In Vitro Diagnostics (IVD) Quality Control Market Overview:

A major factor contributing to the growth of the market is the increasing global prevalence of infectious diseases, HIV and cancer, which require new diagnostic methods for efficient treatment and quality control to monitor their performance. For example, according to the Joint United Nations Program on HIV and AIDS (UNAIDS), 24.5 million people living with HIV were receiving antiretroviral treatment worldwide in 2019. In addition, expansion of government participation in controlling the spread of infectious diseases and increasing demand for quality assessment support along with immediate diagnosis systems are expected to contribute to the growth of the global market during the forecast period.

In Vitro Diagnostics (IVD) Quality Control Market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global In Vitro Diagnostics (IVD) Quality Control Market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Key Market Updates:

• In August 2021, Zeptometrix Corporation (USA) announced the immediate availability of ready-to-use NATSARS (COV2)-ERC for laboratory QC and test validation.
• In July 2021, Quidel Corporation (USA) received CE marking for its innovative Savanna multi-molecular analyzer and Savanna RVP4 assay (Respiratory Virus Panel-4).
• In June 2021, LGC SeraCare (USA) expanded its SARS-CoV-2 molecular quality solution line to include the AccuPlex SARS-CoV-2 Variant Panel 1.
• In June 2021, Abbott Laboratories (USA) received the CE mark for Panbio Rapid Antigen self-test. It has helped the company expand its reach across Europe for fast and reliable COVID-19 testing.

Major Market Segments Covered in In Vitro Diagnostics (IVD) Quality Control Market Industry Research:

Market Key Players:
Siemens Healthcare GmbH, Roche Diagnostics, Alere Inc., Abbott Laboratories Inc., Bio-Techne, Hologic Inc., And Others.

By Type:

• Quality Controls
• Data Management
• Quality Assurance Services
• Other

By Application:

• Clinical Chemistry
• Hematology
• Immunoassay
• Molecular Diagnostics
• Microbiology
• Coagulation/Hemostasis
• Others

By End-User:

• Hospitals
• Clinical/ Reference Laboratories
• Research and Academic Institutes
• Others

By Region:

North America led the global in vitro diagnostic quality control market in 2019 and is expected to maintain its leading position throughout the evaluation period, owing to surging demand for technologically superior multi-assay controls and stringent guidelines for the use of controls. The APAC region is estimated to be a rapidly developing region under the assessment timeline as it has enormous potential for this market due to the increasing number of product manufacturing companies. Besides, the Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine is strengthening the application of IVD. Therefore, increasing awareness of early and accurate diagnosis fuels product demand and ultimately fuels the IVD quality control market in the region. In addition, major regulatory authorities in the region such as the Ministry of Health, Labor and Welfare (MHLW), the Pharmaceutical and Medical Device Evaluation Agency (PMDA), and the Ministry of Agriculture, Fisheries, and Food will support the market growth.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Belgium
  • The Netherlands
  • Luxembourg
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia-Pacific
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Significant Market Dynamics:

Market Driver

• Increase in Accredited Clinical Laboratories
• Increased third-party quality control services
• A favorable presence of regulatory bodies

Market Restraint

• High-cost IVD quality control services
• Adverse reimbursement scenarios in the IVD industry

In Vitro Diagnostics (IVD) Quality Control Market report scope:

Report Attributes	Details
Growth Rate	CAGR of 6.2% from 2022 to 2030.
By Type	Quality Controls, Data Management, Quality Assurance Services
By Application	Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation/Hemostasis, Others
By Companies	Siemens Healthcare GmbH, Roche Diagnostics, Alere Inc., Abbott Laboratories Inc., Bio-Techne, Hologic Inc.
Regions and Countries Covered	North America: (US, Canada, Mexico, Rest of North America) Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe) Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific) The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa) Latin America(Brazil, Argentina, Rest of Latin America) Rest Of the World
Base Year	2022
Historical Year	2017 to 2022
Forecast Year	2023 to 2030

Crucial Points from this In Vitro Diagnostics (IVD) Quality Control Market Report

• Estimate In Vitro Diagnostics (IVD) Quality Control Market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, applications and by different industry verticals.
• Understand the supply chain in depth on the value growth at each step, in order to optimize value and bring effectiveness in your processes.
• Know the different dynamics affecting the market - challenges, key driving factors and opportunities.
• Get a quick viewpoint on the In Vitro Diagnostics (IVD) Quality Control Market entropy - M&A's, deals, partnerships, product launches of all key companies for the historical 5 years.
• Estimate the supply-demand gaps, import-export data and regulatory landscape for more than top 20 countries worldwide for the market.
• Get complete insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Study the sales and distribution channels over key geographies to improve top-line revenues.

Frequently Asked Questions-

1. What is the CAGR of In Vitro Diagnostics (IVD) Quality Control Market?
2. What are the key types of In Vitro Diagnostics (IVD) Quality Control Market?
3. What are the key applications of In Vitro Diagnostics (IVD) Quality Control Market?
4. Who are the key players in In Vitro Diagnostics (IVD) Quality Control Market?